Xometry Inc
For the period ended Mar 31, 2025. Filed May 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 6, 2025
XMTR$119.31-1.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
Cash Flows
(In thousands)
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net loss | $(15,076) | $(16,604) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 4,246 | 3,153 |
| Reduction in carrying amount of right-of-use asset | 1,100 | 1,096 |
| Lease termination | (30) | — |
| Stock-based compensation | 7,342 | 6,036 |
| Revaluation of contingent consideration | — | 137 |
| Income from unconsolidated joint venture | (90) | (97) |
| Donation of common stock | 516 | 343 |
| Amortization of deferred costs on convertible notes | 465 | 464 |
| Changes in other assets and liabilities: | ||
| Accounts receivable, net | (13,358) | 532 |
| Inventory | (41) | (40) |
| Prepaid expenses | (1,519) | (433) |
| Other assets | (1,995) | (442) |
| Accounts payable and accrued cost of revenue | 15,048 | (10,649) |
| Other accrued expenses | (540) | 4,440 |
| Contract liabilities | 1,877 | 2,277 |
| Lease liabilities | (1,531) | (1,671) |
| Other liabilities | (13) | — |
| Income taxes payable | (92) | (276) |
| Net cash used in operating activities | (3,691) | (11,734) |
| Cash flows from investing activities: | ||
| Purchases of marketable securities | (2,271) | (2,726) |
| Proceeds from sale of marketable securities | 4,000 | 10,000 |
| Purchases of property and equipment | (5,499) | (4,347) |
| Distributions in excess of earnings | 84 | — |
| Net cash (used in) provided by investing activities | (3,686) | 2,927 |
| Cash flows from financing activities: | ||
| Proceeds from stock options exercised | 510 | 1,233 |
| Net cash provided by financing activities | 510 | 1,233 |
| Effect of foreign currency translation on cash and cash equivalents | 142 | (149) |
| Net decrease in cash and cash equivalents | (6,725) | (7,723) |
| Cash and cash equivalents at beginning of the period | 22,232 | 53,424 |
| Cash and cash equivalents at end of the period | $15,507 | $45,701 |
| Supplemental cash flow information: | ||
| Cash paid for interest | $1,438 | $1,438 |
| Non-cash investing and financing activities: | ||
| Non-cash consideration in connection with business combination | 625 | — |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.